Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A.

Abstract

Interstitial cells of Cajal, which express the calcium-activated chloride channel transmembrane member 16A (TMEM16A), are an important determinant of gastrointestinal (GI) motility. We previously identified the acylaminocycloalkylthiophene class of TMEM16A inhibitors, which, following medicinal chemistry, gave analog 2-bromodifluoroacetylamino-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylic acid o-tolylamide (TMinh-23) with 30 nM half-maximal inhibitory concentration. Here, we tested the efficacy of TMinh-23 for inhibition of GI motility in mice. In isolated murine gastric antrum, TMinh-23 strongly inhibited spontaneous and carbachol-stimulated rhythmic contractions. Pharmacokinetic analysis showed predicted therapeutic concentrations of TMinh-23 for at least 4 h following a single oral or intraperitoneal dose at 10 mg/kg. Gastric emptying, as assessed following an oral bolus of phenol red or independently by [99mTc]-diethylenetriamine pentaacetic acid scintigraphy, was reduced by TMinh-23 by ∼60% at 20 min. Interestingly, there was little effect of TMinh-23 on baseline whole-gut transit time or time to diarrhea induced by castor oil. Consequent to the delay in gastric emptying, TMinh-23 administration significantly reduced the elevation in blood sugar in mice following an oral but not intraperitoneal glucose load. These results provide pharmacological evidence for involvement of TMEM16A in gastric emptying and suggest the utility of TMEM16A inhibition in disorders of accelerated gastric emptying, such as dumping syndrome, and potentially for improving glucose tolerance in diabetes mellitus/metabolic syndrome and enhancing satiety in obesity.-Cil, O., Anderson, M. O., Yen, R., Kelleher, B., Huynh, T. L., Seo, Y., Nilsen, S. P., Turner, J. R., Verkman, A. S. Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A.

• Authors: Onur Cil, Marc O Anderson, Robert Yen, Bryan Kelleher, Tony L Huynh, Youngho Seo, Steven P Nilsen, Jerrold R Turner, Alan S Verkman
• Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 33 Issue 10 Pg. 11247-11257 (10 2019) ISSN: 1530-6860 [Electronic] United States
• PMID: 31299174 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• ANO1 protein, human
• ANO1 protein, mouse
• Anoctamin-1
• Blood Glucose
• Chloride Channel Agonists
• Chloride Channels
• Chlorides
• Neoplasm Proteins
• Glucose
• Calcium

Topics

• Animals
• Anoctamin-1 (metabolism)
• Blood Glucose (drug effects)
• Calcium (metabolism)
• Chloride Channel Agonists (pharmacology)
• Chloride Channels (metabolism)
• Chlorides (metabolism)
• Female
• Gastric Emptying (drug effects)
• Gastrointestinal Motility (drug effects)
• Glucose (metabolism)
• Glucose Tolerance Test (methods)
• Humans
• Mice
• Neoplasm Proteins (metabolism)